Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial

BACKGROUND: Prescription digital therapeutics are software-based disease treatments that are regulated by the US Food and Drug Administration; the reSET-O prescription digital therapeutic was authorized in 2018 and delivers behavioral treatment for individuals receiving buprenorphine for opioid use...

Descripción completa

Detalles Bibliográficos
Autores principales: Luderer, Hilary, Chiodo, Lisa, Wilson, Amanda, Brezing, Christina, Martinez, Suky, Xiong, Xiaorui, Gerwien, Robert, Imbert, Bruce, Deeg, Mark, Maricich, Yuri, Campbell, Aimee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829697/
https://www.ncbi.nlm.nih.gov/pubmed/35080499
http://dx.doi.org/10.2196/32759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829697/
https://www.ncbi.nlm.nih.gov/pubmed/35080499
http://dx.doi.org/10.2196/32759

Ejemplares similares